Status:
RECRUITING
Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI
Lead Sponsor:
Benha University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
15-65 years
Brief Summary
The goal of this observational study is to compare the diagnostic accuracy of Phase-Sensitive Inversion Recovery (PSIR) MRI versus conventional T2-weighted (T2W) and Fluid Attenuated Inversion Recover...
Detailed Description
Introduction Multiple sclerosis (MS) is an immune, demyelinating disease that assaults myelinated axons in the central nervous system (CNS), damaging the myelin and axon to varying degrees. Inflammati...
Eligibility Criteria
Inclusion
- Age between 15-65 years.
- Both sexes.
- Patients with MS according to McDonald Criterion
Exclusion
- Age less than 15 years old.
- Patients with stroke or previous intracranial hemorrhage.
- Contraindications to MRI scans.
- MS mimics.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06955832
Start Date
June 1 2025
End Date
October 1 2025
Last Update
May 18 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Banha University Hospitals
Banhā, Qalyubia Governorate, Egypt
2
El Mounira Multiple Sclerosis Unit
Cairo, Egypt
3
Naser Institute MS Unit
Cairo, Egypt